GLP-1 clinical trials enrolling now. Find one near you.
177 GLP-1 clinical trials covering 122 conditions are recruiting across 48 US states as of September 4, 2026. You pay nothing for the medication.
In every clinical trial here, the study medication and trial visits cost you nothing, and many pay you for your time. Some participants get a placebo, assigned at random.
Filters
177 of 177 clinical trials match. Showing the first 20
- Who can join
- Adults 18+, have fatty liver disease (MASLD), BMI 25+.
- Where
- Alabama, Arizona and 33 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Children and teens 8 to 18, are overweight.
- Where
- California, Florida and 17 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 35+.
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH), BMI 25+.
- Where
- Arizona, California and 23 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 23+.
- Where
- Alabama, Arizona and 29 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.Enrolling
- Who can join
- Children and teens 6 to 17, have obesity.
- Where
- Arizona, California and 27 more states
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people ease joint pain.Enrolling
- Who can join
- Adults 18+, have osteoarthritis (joint pain), BMI 27+.
- Where
- Arizona, California and 15 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have peripheral artery disease (poor blood flow in the legs), BMI 23+.
- Where
- Alabama, Arizona and 12 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, women only, have stress urinary incontinence (bladder leaks), BMI 27+.
- Where
- Alabama, Arizona and 9 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity or are overweight, BMI 25+.
- Where
- Alabama, Arizona and 16 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have Crohn's disease, BMI 27+.
- Where
- Alabama, California and 20 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 35+.
- Where
- Arizona, Arkansas and 17 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have ulcerative colitis, BMI 27+.
- Where
- Alabama, California and 21 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 23+.
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity, BMI 27+.
- Where
- Arizona, California and 20 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes.
- Where
- Alabama, California and 12 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes, BMI 27+.
- Where
- Arizona, California and 12 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.Enrolling
- Who can join
- Children and teens 12 to 17, have obesity.
- Where
- California, Connecticut and 8 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have obesity, BMI 30+.
- Where
- Alabama, California and 15 more states
Study details
View on ClinicalTrials.gov →
Not sure which clinical trial fits you? Answer no more than 8 short questions, one per screen. We show you the clinical trials that fit your age, where you live, and the rules each one sets.
Take the quiz →How this directory works
The data comes from ClinicalTrials.gov, the US federal registry for clinical research. We pull active and pre-active GLP-1 clinical trials (semaglutide, tirzepatide, liraglutide, retatrutide, survodutide, orforglipron, cagrisema and related molecules) plus studies of GLP-1 effects on conditions like obesity, type 2 diabetes, MASH, sleep apnea, CKD, and cardiovascular disease.
Every Monday we check these listings against ClinicalTrials.gov. Before you contact a site, click through to its registry record and confirm the clinical trial is still recruiting. For the wider picture on getting a GLP-1 at no cost, see how to get a GLP-1 for free.
How to enroll in a clinical trial
- Find a clinical trial below or take the matching quiz. Read the eligibility criteria. The key inclusion and exclusion items are the ones the trial coordinator will check first.
- Find a site location near you. We list every US site with city, state, and contact information when the sponsor publishes it.
- Contact the site directly using the phone or email on the trial page. Tell them you read about the trial on GLP Chart and you want to be screened.
- Screening typically involves a phone call, a clinic visit, and sometimes blood work. Most clinical trials cover the cost of screening and trial-related medical care. Some sites compensate participants for their time; the trial coordinator explains what each site offers.
- If you do not qualify for the trial you contacted, ask the site coordinator about other clinical trials they run. Many sites run multiple GLP-1 studies at once and can route you to a better fit.
If a trial is not a fit and you need treatment now, the GLP-1 cost guide lays out what every legitimate cash-pay path costs at maintenance dose, starting at $149 a month for compounded semaglutide.
A few legal notes
GLP Chart is not affiliated with any of the sponsors or sites listed. We do not enroll patients in clinical trials, and we are not paid for clinical-trial referrals. If that changes, this page will say so on the day it does.
Participating in a clinical trial is a serious medical decision. Talk to your existing healthcare provider before enrolling. Trial coordinators are required by federal regulation to walk you through informed consent before you join.
GLP-1 clinical trials by state
1619 recruiting sites across 48 states. The number beside each state is how many studies are enrolling there.
- Alabama (16)
- Arizona (21)
- Arkansas (6)
- California (51)
- Colorado (18)
- Connecticut (12)
- Delaware (1)
- District of Columbia (1)
- Florida (40)
- Georgia (23)
- Hawaii (4)
- Idaho (11)
- Illinois (29)
- Indiana (19)
- Iowa (7)
- Kansas (13)
- Kentucky (15)
- Louisiana (15)
- Maine (1)
- Maryland (22)
- Massachusetts (19)
- Michigan (18)
- Minnesota (17)
- Mississippi (6)
- Missouri (21)
- Montana (4)
- Nebraska (5)
- Nevada (11)
- New Hampshire (3)
- New Jersey (12)
- New Mexico (4)
- New York (28)
- North Carolina (30)
- North Dakota (3)
- Ohio (28)
- Oklahoma (12)
- Oregon (4)
- Pennsylvania (32)
- Rhode Island (7)
- South Carolina (20)
- South Dakota (2)
- Tennessee (26)
- Texas (55)
- Utah (14)
- Virginia (26)
- Washington (24)
- West Virginia (4)
- Wisconsin (7)
48 more studies have not opened enrollment
ClinicalTrials.gov lists these as not yet recruiting. Open a study's registry record to see whether the sponsor has posted a start date.
- Eli Lilly and Company, overweight, phase 3. NCT07794579 on ClinicalTrials.gov
- Novo Nordisk A/S, diabetes mellitus type 2, phase 3. NCT07282613 on ClinicalTrials.gov
- Eli Lilly and Company, diabetes mellitus type 2, phase 3. NCT07668336 on ClinicalTrials.gov
- Novo Nordisk A/S, overweight, phase 3. NCT07668414 on ClinicalTrials.gov
- Novo Nordisk A/S, obesity, phase 3. NCT07400107 on ClinicalTrials.gov
- Biomed Industries, Inc, obesity and overweight, phase 2. NCT06732245 on ClinicalTrials.gov
- Massachusetts General Hospital, obesity, phase 4. NCT07729332 on ClinicalTrials.gov
- University of Virginia, obesity & overweight, phase 3. NCT07298915 on ClinicalTrials.gov
- University of Colorado, Denver, obesity/therapy, phase 3. NCT07021937 on ClinicalTrials.gov
- Washington University School of Medicine, lower back pain, phase 2. NCT07731256 on ClinicalTrials.gov
- Eli Lilly and Company, diabetes mellitus type 1, phase 1. NCT07803744 on ClinicalTrials.gov
- Vanderbilt University Medical Center, type 2 diabetes mellitus (t 2 DM), phase 2. NCT07760948 on ClinicalTrials.gov
- University of North Carolina, Chapel Hill, pouch ileal, phase 4. NCT07756359 on ClinicalTrials.gov
- National Cancer Institute (NCI), endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia, phase 2. NCT07349641 on ClinicalTrials.gov
- Johns Hopkins University, alcohol use disorder, phase 2. NCT07249554 on ClinicalTrials.gov
- University of Massachusetts, Worcester, gestational diabetes mellitus (GDM), phase 2. NCT07797036 on ClinicalTrials.gov
- Children's Hospital Medical Center, Cincinnati, stage 1 diabetes mellitus type 1, phase 2. NCT07430332 on ClinicalTrials.gov
- The Cleveland Clinic, COPD, phase 2. NCT07747805 on ClinicalTrials.gov
- Noom Inc, obesity & overweight. NCT07588984 on ClinicalTrials.gov
- SIPPA Solutions INC, type 2 diabetes. NCT07032311 on ClinicalTrials.gov
- Johns Hopkins University, central centrifugal cicatricial alopecia (CCCA), phase 2. NCT07734870 on ClinicalTrials.gov
- Goldman, Butterwick, Fitzpatrick and Groff, wrinkle, phase 2. NCT07221461 on ClinicalTrials.gov
- Mayo Clinic, genetic predisposition, phase 2. NCT06972407 on ClinicalTrials.gov
- William Marsh Rice University, GLP - 1, phase 4. NCT07554417 on ClinicalTrials.gov
- University of Minnesota, obesity childhood, phase 4. NCT06977438 on ClinicalTrials.gov
- Stanford University, prediabetes / type 2 diabetes, phase 4. NCT06682351 on ClinicalTrials.gov
- Goldman, Butterwick, Fitzpatrick and Groff, laxity skin, phase 2. NCT07217743 on ClinicalTrials.gov
- Baylor Research Institute, chronic kidney disease, phase 4. NCT07547878 on ClinicalTrials.gov
- Children's Hospital Medical Center, Cincinnati, autism spectrum disorder, phase 4. NCT07770152 on ClinicalTrials.gov
- UNC Lineberger Comprehensive Cancer Center, endometrial cancer, phase 2. NCT07078838 on ClinicalTrials.gov
- Ali Aminian, atrial fibrillation, phase 4. NCT07027969 on ClinicalTrials.gov
- Ponsky Facial Aesthetics And Plastic Surgery, Llc, facial skin aging. NCT07760532 on ClinicalTrials.gov
- Mayo Clinic, anatomic stage i breast cancer AJCC v 8, phase 4. NCT07769047 on ClinicalTrials.gov
- Yale University, alcohol use disorder (AUD), phase 1. NCT07772960 on ClinicalTrials.gov
- University of Wisconsin, Madison, GLP-1, phase 1. NCT07758231 on ClinicalTrials.gov
- Louisiana State University and A&M College, women's health. NCT07787533 on ClinicalTrials.gov
- Hartford HealthCare, lower urinary tract symptoms. NCT07175805 on ClinicalTrials.gov
- University of Chicago, lung cancer, phase 1. NCT07782359 on ClinicalTrials.gov
- Vanderbilt University Medical Center, duchenne muscular dystrophy (DMD), phase 1. NCT07642635 on ClinicalTrials.gov
- Pennington Biomedical Research Center, obesity. NCT07796204 on ClinicalTrials.gov
- University of Alabama at Birmingham, weight loss. NCT07535892 on ClinicalTrials.gov
- Oelisoa Andriankaja, obesity. NCT07478653 on ClinicalTrials.gov
- The Cleveland Clinic, type 2 diabetes. NCT07695454 on ClinicalTrials.gov
- Banner Health, prostate cancer, phase 1. NCT07727473 on ClinicalTrials.gov
- University of Arizona, pancreatic cancer, phase 1. NCT07627191 on ClinicalTrials.gov
- The Cleveland Clinic, diabetes. NCT07784127 on ClinicalTrials.gov
- Tufts University, weight maintenance. NCT07701460 on ClinicalTrials.gov
- Goldman, Butterwick, Fitzpatrick and Groff, laxity skin. NCT07558603 on ClinicalTrials.gov
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.